Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123348872 | 12334887 | 2 | F | 20160430 | 20160624 | 20160504 | 20160701 | EXP | US-TAKEDA-2016MPI003641 | TAKEDA | 65.45 | YR | M | Y | 0.00000 | 20160701 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123348872 | 12334887 | 1 | PS | VELCADE | BORTEZOMIB | 1 | Subcutaneous | 1.92 MG, UNK | 21602 | 1.92 | MG | INJECTION | |||||||
| 123348872 | 12334887 | 2 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 40 MG, 1/WEEK | 0 | 40 | MG | /wk | |||||||
| 123348872 | 12334887 | 3 | C | ACYCLOVIR /00587301/ | ACYCLOVIR | 1 | Oral | UNK, QD | U | 0 | TABLET | QD | |||||||
| 123348872 | 12334887 | 4 | C | CENTRUM SILVER /02363801/ | MINERALSVITAMINS | 1 | Oral | U | 0 | TABLET | QD | ||||||||
| 123348872 | 12334887 | 5 | C | CLOTRIMAZOLE. | CLOTRIMAZOLE | 1 | Oral | 10 MG, UNK | U | 0 | 10 | MG | TABLET | ||||||
| 123348872 | 12334887 | 6 | C | DILTIAZEM CD | DILTIAZEM | 1 | Oral | 240 MG, UNK | U | 0 | 240 | MG | CAPSULE | ||||||
| 123348872 | 12334887 | 7 | C | ACETAMINOPHEN W/HYDROCODONE | ACETAMINOPHENHYDROCODONE | 1 | Oral | UNK | U | 0 | TABLET | ||||||||
| 123348872 | 12334887 | 8 | C | METHADONE HYDROCHLORIDE. | METHADONE HYDROCHLORIDE | 1 | Oral | 5 MG, TID | U | 0 | 5 | MG | TABLET | TID | |||||
| 123348872 | 12334887 | 9 | C | ONDANSETRON HYDROCHLORIDE. | ONDANSETRON HYDROCHLORIDE | 1 | Oral | 8 MG, UNK | U | 0 | 8 | MG | TABLET | ||||||
| 123348872 | 12334887 | 10 | C | SENNA /00142201/ | SENNA LEAF | 1 | Oral | 8.6 MG, QD | U | 0 | 8.6 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123348872 | 12334887 | 1 | Plasma cell myeloma |
| 123348872 | 12334887 | 2 | Plasma cell myeloma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123348872 | 12334887 | DE |
| 123348872 | 12334887 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123348872 | 12334887 | Plasma cell myeloma |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123348872 | 12334887 | 1 | 20160102 | 0 |